Biology Reference
In-Depth Information
13. Celis JE, Gromov P. Proteomics in translational cancer
research: Toward an integrated approach.
Cancer Cell
2003;3:9
e
15.
14. Chiechi A, Mueller C, Boehm KM, et al. Improved
data normalization methods for reverse phase protein
microarray analysis of complex biological samples.
BioTechniques
2012;Sep(0):1
e
7.
15. Dash A, Maine IP, Varambally S, Shen R,
Chinnaiyan AM, Rubin MA. Changes in differential
gene expression because of warm ischemia time of
radical prostatectomy specimens.
Am J Pathol
2002;
161:1743
e
8.
16. Davidson B, Espina V, Steinberg SM, et al. Proteomic
analysis of malignant ovarian cancer effusions as
a tool for biologic and prognostic pro
27. Espina V, Woodhouse EC, Wulfkuhle J, et al. Protein
microarray detection strategies: focus on direct detec-
tion technologies.
J Immunol Methods
2004;290:121
e
33.
28. Fox CH, Johnson FB, Whiting J, et al. Formaldehyde
fixation.
J Histochem Cytochem
1985;33:845
e
53.
29. Gangadhar T, Schilsky RL. Molecular markers to
individualize adjuvant therapy for colon cancer.
Nat
Rev Clin Oncol
2010;7:318
e
25.
30. Goldenberg MM. Trastuzumab, a recombinant
DNA-derived humanized monoclonal antibody,
a novel agent for the treatment of metastatic breast
cancer.
Clin Ther
1999;21:309
e
18.
31. Grellner W. Time-dependent
immunohistochemical
ammatory cytokines (IL-1beta, IL-
6, TNF-alpha) in human skin wounds.
Forensic Sci
Int
2002;130:90
e
6.
32. Grellner W, Madea B. Demands on scienti
detection of proin
ling.
Clin Cancer
Res
2006;12:791
e
9.
17. Davuluri G, Espina V, Petricoin EF, et al. Activated
VEGF receptor shed into the vitreous in eyes with wet
AMD: a new class of biomarkers in the vitreous with
potential for predicting the treatment timing and
monitoring response.
Arch Ophthalmol
c studies:
vitality of wounds and wound age estimation.
Forensic
Sci Int
2007;165:150
e
4.
33. Grellner W, Vieler S, Madea B. Transforming growth
factors (TGF-alpha and TGF-beta1) in the determina-
tion of vitality and wound age: immunohistochemical
study on human skin wounds.
Forensic Sci Int
2005;
153:174
e
80.
34. Grubb RL, Calvert VS, Wulkuhle JD, et al. Signal
pathway pro
2009;127:
613
e
21.
18. Doolan DL, Mu Y, Unal B, et al. Pro
ling humoral
immune responses to P. falciparum infection with
protein microarrays.
Proteomics
2008;8:4680
e
94.
19. Dupuy L, Gauthier C, Durand G, et al. A highly
sensitive near-infrared
ling of prostate cancer using reverse
phase protein arrays.
Proteomics
2003;3:2142
e
6.
35. Gulmann C, Espina V, Petricoin III E, et al. Proteomic
analysis of apoptotic pathways reveals prognostic
factors in follicular lymphoma.
Clin Cancer Res
2005;
11:5847
e
55.
36. Haab BB, Dunham MJ, Brown PO. Protein micro-
arrays for highly parallel detection and quantitation of
speci
fluorescent detection method to
analyze signalling pathways by reverse-phase protein
array.
Proteomics
2009;9:5446
e
54.
20. Ekins RP. Multi-analyte immunoassay.
J Pharm Biomed
Anal
1989;7:155
e
68.
21. Ekins RP, Chu FW. Multianalyte microspot
immunoassay
d
microanalytical
“
compact disk
”
of the
future.
Clin Chem
1991;37:1955
e
67.
22. El Khoury G, Laurenceau E, Chevolot Y, et al.
Development of miniaturized immunoassay: in
c proteins and antibodies in complex solutions.
Genome Biol
2001;2001:2.RESEARCH0004.
37. Havaleshko DM, Smith SC, Cho H, et al. Comparison
of global versus epidermal growth factor receptor
pathway pro
uence
of surface chemistry and comparison with enzyme-
linked immunosorbent assay and Western blot.
Anal
Biochem
2010;400:10
e
8.
23. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser
capture microdissection.
Science
1996;274:998
e
1001.
24. Espina V, Edmiston KH, Heiby M, et al. A portrait of
tissue phosphoprotein stability in the clinical tissue
procurement process.
Mol Cell Proteomics
2008;7:
1998
e
2018.
25. Espina V, Mariani BD, Gallagher RI, et al. Malignant
precursor cells pre-exist in human breast DCIS and
require autophagy for survival.
PLoS ONE
2010;5:
e10240.
26. Espina V, Mueller C, Edmiston KH, et al. Tissue is
alive: new technologies are needed to address the
problems of protein biomaker pre-analytical vari-
ability.
Proteomics Clin Appl
2009;3:874
e
82.
ling for prediction of lapatinib sensi-
tivity in bladder cancer.
Neoplasia
2009;11:1185
e
93.
38. Helander KG. Kinetic studies of formaldehyde
binding in tissue.
Biotech Histochem
1994;69:177
e
9.
39. Hennessy BT, Gonzalez-Angulo A-M, Stemke-Hale K,
et al. Characterization of a naturally occurring breast
cancer subset enriched in epithelial-to-mesenchymal
transition and stem cell characteristics.
Cancer Res
2009;69:4116
e
24.
40. Hideshima T, Mitsiades C, Tonon G, et al. Under-
standing multiple myeloma pathogenesis in the bone
marrow to identify new therapeutic targets.
Nat Rev
Cancer
2007;7:585
e
98.
41. Hong B, Lui VWY, Hui EP, et al. Reverse phase
protein array identi
es novel anti-invasion mecha-
nisms of YC-1.
Biochem Pharmacol
2010;79:842
e
52.
Search WWH ::
Custom Search